Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Emoto

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Diabetes Care|May 12, 2001
Glycemic control is a predictor of survival for diabetic patients on hemodialysisT Morioka, M Emoto, T Tabata, et al.
Cancer|April 1, 1992
Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analysesM Emoto, H Iwasaki, M Kikuchi, et al.
Clinical Nephrology|April 1, 1995
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patientsY Nishizawa, T Shoji, M Emoto, et al.
Journal of Leukocyte Biology|December 1, 1989
Alterations of host resistance to mouse typhoid infection by sex hormonesE Kita, Y Yagyu, F Nishikawa, et al.
European Journal of Endocrinology|February 22, 2001
Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathyY Kurioka, M Inaba, T Kawagishi, et al.
Diabetes|May 4, 2001
Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytesM Emoto, T Anno, Y Sato, et al.
Atherosclerosis|August 14, 2001
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitusH Taniwaki, T Shoji, M Emoto, et al.
Clinical Nephrology|September 1, 1992
A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patientsA Morita, T Tabata, H Koyama, et al.
Journal of Medical Microbiology|November 1, 1990
Hepatotoxic activity of Campylobacter jejuniE Kita, D Oku, A Hamuro, et al.
Journal of Nutritional Science and Vitaminology|December 1, 1991
Effects of dietary phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatmentT Tabata, S Shoji, A Morita, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Diabetes Care|May 12, 2001
Glycemic control is a predictor of survival for diabetic patients on hemodialysisT Morioka, M Emoto, T Tabata, et al.
Cancer|April 1, 1992
Two cell lines established from mixed müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analysesM Emoto, H Iwasaki, M Kikuchi, et al.
Clinical Nephrology|April 1, 1995
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patientsY Nishizawa, T Shoji, M Emoto, et al.
Journal of Leukocyte Biology|December 1, 1989
Alterations of host resistance to mouse typhoid infection by sex hormonesE Kita, Y Yagyu, F Nishikawa, et al.
European Journal of Endocrinology|February 22, 2001
Increased retinal blood flow in patients with Graves' disease: influence of thyroid function and ophthalmopathyY Kurioka, M Inaba, T Kawagishi, et al.
Diabetes|May 4, 2001
Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytesM Emoto, T Anno, Y Sato, et al.
Atherosclerosis|August 14, 2001
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitusH Taniwaki, T Shoji, M Emoto, et al.
Clinical Nephrology|September 1, 1992
A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patientsA Morita, T Tabata, H Koyama, et al.
Journal of Medical Microbiology|November 1, 1990
Hepatotoxic activity of Campylobacter jejuniE Kita, D Oku, A Hamuro, et al.
Journal of Nutritional Science and Vitaminology|December 1, 1991
Effects of dietary phosphorus restriction on secondary hyperparathyroidism in hemodialysis patients during intermittent oral high-dose 1,25(OH)2D3 treatmentT Tabata, S Shoji, A Morita, et al.
Pageof 15